CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $14.00 thousand for the 9-month period ending 2019-08-31, per its 10-Q filed 2020-10-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2020-10-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2018-02-28 was $1.20M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month |
|---|---|---|
| 2019-08-31 | $14.00K 10-Q · filed 2020-10-15 | |
| 2018-02-28 | $1.20M 10-Q · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |